Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Magnetocardiographic indices of left ventricular hypertrophy.
Karvonen M, Oikarinen L, Takala P, Kaartinen M, Rossinen J, Hänninen H, Montonen J, Nenonen J, Mäkijärvi M, Keto P, Toivonen L, Nieminen MS, Katila T. Karvonen M, et al. Among authors: nieminen ms. J Hypertens. 2002 Nov;20(11):2285-92. doi: 10.1097/00004872-200211000-00029. J Hypertens. 2002. PMID: 12409968 Clinical Trial.
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Oikarinen L, Nieminen MS, Viitasalo M, Toivonen L, Jern S, Dahlöf B, Devereux RB, Okin PM; LIFE Study Investigators. Oikarinen L, et al. Among authors: nieminen ms. Hypertension. 2004 May;43(5):1029-34. doi: 10.1161/01.HYP.0000125230.46080.c6. Epub 2004 Mar 22. Hypertension. 2004. PMID: 15037560 Clinical Trial.
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahlöf B, Devereux RB. Okin PM, et al. Among authors: nieminen ms. Am J Hypertens. 2002 Aug;15(8):663-71. doi: 10.1016/s0895-7061(02)02945-x. Am J Hypertens. 2002. PMID: 12160187
Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.
Oikarinen L, Nieminen MS, Toivonen L, Viitasalo M, Wachtell K, Papademetriou V, Jern S, Dahlöf B, Devereux RB, Okin PM; LIFE Study Investigators. Oikarinen L, et al. Among authors: nieminen ms. Am Heart J. 2003 May;145(5):919-25. doi: 10.1016/S0002-8703(02)94785-X. Am Heart J. 2003. PMID: 12766755 Clinical Trial.
ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
Porthan K, Kenttä T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, Hernesniemi J, Jula AM, Salomaa V, Huikuri HV, Albert CM, Tikkanen JT. Porthan K, et al. Among authors: nieminen ms. Int J Cardiol. 2019 Feb 1;276:125-129. doi: 10.1016/j.ijcard.2018.09.104. Epub 2018 Sep 27. Int J Cardiol. 2019. PMID: 30293667 Free article.
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
Okin PM, Wachtell K, Devereux RB, Nieminen MS, Oikarinen L, Viitasalo M, Toivonen L, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Kjeldsen SE, Julius S, Dahlöf B; LIFE Study Investigators. Okin PM, et al. Among authors: nieminen ms. Am J Hypertens. 2008 Mar;21(3):273-9. doi: 10.1038/ajh.2007.66. Epub 2008 Jan 24. Am J Hypertens. 2008. PMID: 18219298 Clinical Trial.
461 results